3. Decisions about Gender Affirming Hormone Treatment
This section of the article outlines the key legal developments relevant to the commencement of gender affirming hormone treatment. The purpose is to outline how the law has developed in this area, in relation to both Australian and English law, so that an analysis of the Australian law can be undertaken in Part 4 of the article.
In Australia, the law relevant to minors’ consent to the commencement of gender affirming hormone treatment has developed incrementally, by way of common law. The legal principles of significance have emerged from the field of caselaw relevant to “special medical procedures”, which is focused on whether some types of medical decisions fall outside the boundaries of the parental power to consent. Although a detailed discussion of the issue of parental consent is beyond the scope of this paper, an overview of this body of jurisprudence is necessary for the purpose of explaining how the reasoning relevant to Gillick competency in this field has developed. Thus, the development of the law in Australia relevant to minors’ decision-making and consent to hormone treatment is entangled with the law relevant to parental consent for this purpose, which mandates a discussion of both areas of law.
The cases relevant to gender affirming treatment have relied on the decision of the High Court of Australia (High Court) in
Secretary, Department of Health and Community Services (NT) v JWB46 (Marion’s Case). This decision considered whether parents could lawfully consent to a sterilisation procedure for their child with profoundly disability.
Marion’s Case established the foundational legal rules that determine the types of medical decision that might fall outside of the parental power to consent. This High Court authority remains as binding precedent relevant to the issue of children’s consent, as it has not been departed from. However, it has been heavily criticised, with others noting that the impact of the decision requires reform (
Stewart 2017).
The High Court was asked to determine whether Marion’s parents could lawfully consent to a sterilisation procedure. In the circumstances of the case, the procedure was not regarded as therapeutic because it was not for the purpose of treating a physical disease or illness. Instead, it was to address, among other things, behavioural issues and alleviate significant future distress. The decision is complex, but in simple terms, although the High Court held that parents are normally the lawful decision makers in respect of medical treatment decisions for their children,
47 there is a need to involve the court in relation to some treatment decisions made by parents. Court involvement was considered to be a procedural safeguard due to the serious and irreversible nature of the intervention in question, thereby removing this type of decision from the parental power to consent. The High Court reasoned that court involvement is required in cases where a procedure or intervention is non-therapeutic and where there are, what I term, “further factors” of concern. The further factors discussed in
Marion’s Case include where the procedure or intervention is grave,
48 invasive and irreversible, where there is a risk that a wrong decision will be made concerning the minor’s present or future capacity to consent,
49 and where a potential conflict exists between the interests of the decision-makers and treating health professionals.
50 Consequently, as the issue of non-therapeutic sterilisation met these elements, it was not something that Marion’s parents could lawfully consent to and the decision about whether the procedure should be performed was subsequently determined by the court.
51Although, strictly speaking,
Marion’s Case set a precedent that applied to non-therapeutic sterilisation procedures, the decision was later applied to other categories of medical treatment or intervention.
52 As explained below, this resulted in the reasoning from
Marion’s Case being applied to cases concerning hormone treatment for gender dysphoria.
Importantly, it should be noted that
Gillick was approved in
Marion’s Case as part of the Australian common law.
53 Technically,
Gillick was affirmed by the Australian High Court on an
obiter basis, given that the minor concerned was not
Gillick competent and the primary question before the Australian High Court was whether Marion’s parents could consent to a non-therapeutic sterilisation procedure.
In contrast to the position under English law, there has been some difference in interpretation in terms of how
Gillick has been applied in Australia. In relation to the
court’s power to override a minor’s decision about medical treatment, the position in Australia is similar to that outlined above in relation to English law. Thus, Australian cases have confirmed that the court has a very wide power to make decisions for and on behalf of minors, and that under the
parens patriae jurisdiction it is the minor’s welfare and best interests that must be prioritised by the court.
54 It should be noted, however, that the vast majority of cases concerning gender affirming treatment have been dealt with by the Family Court, rather than the state and territory supreme courts. This is an important point of distinction because although the Family Court’s welfare jurisdiction in respect of decisions about children is similarly focused on the welfare and best interests of the child, it is not technically as wide as the
parens patriae jurisdiction, as the welfare jurisdiction is created by statute rather than emerging from an inherent power.
55In relation to the parental power, in
Marion’s Case McHugh J affirmed the position in
Gillick that once a minor is regarded as competent to make their own decisions about treatment, the parental power to consent comes to an end,
56 and that the position adopted in the English refusal cases is inconsistent with
Gillick.
57 This means that, at least concerning the parental power, Australian law seems to adopt a different approach to the law in England and Wales, specifically in relation to the position adopted in
Re W, which confirms that parents have a right to veto the refusal of life saving treatment by a
Gillick competent minor. As noted by
Mathews and Smith (
2018, pp. 190–91), what is likely in Australia ‘is that if a
Gillick-competent child refused treatment that would save or prolong his or her life (whether or not the parents consented to the treatment), the court would override the child’s refusal in its
parens patriae jurisdiction’.
Under the authority of Marion’s Case, in relation to medical decisions made by Gillick competent minors, there is no parental power to veto the minor’s decision (even in cases of refusal). However, similar to the position under English law, the court does have a very wide power to interfere and overrule the minor’s consent to, or refusal of, treatment. Despite this, as discussed below, this does not seem to be the position adopted by the Family Court in the specific context of decisions about gender affirming treatment.
3.1. Australian Law Relevant to Minors and Hormone Treatment for Gender Dysphoria
The 2004 Family Court decision of
Re Alex58 was the first Australian case to establish that hormone treatment for gender dysphoria should be regarded as a special medical procedure. The decision determined that both Stage 1 (puberty blockers) and Stage 2 treatment (gender affirming hormones) must be approved by the court. Applying
Marion’s Case, Nicholson CJ held that both stages should be treated as non-therapeutic due to the purpose of the treatment being to treat a psychological condition rather than a physical disease or illness.
59 Nicholson CJ also determined that both stages of treatment should be considered together as a single treatment plan and held that both required the approval of the court. With reference to the further factors from
Marion’s Case, it was held that because the two stages of treatment carried permanent, irreversible, and grave consequences, and that there was a risk of making a wrong decision without the involvement of the court, there was a requirement for the court to make the decision rather than a parent or guardian.
60In relation to the issue of
Gillick competency, Nicholson CJ determined that the question of whether the minor is competent is, based on the reasoning in
Marion’s Case, a threshold issue. This required the court to consider ‘whether Alex had achieved “a sufficient understanding and intelligence to enable him or her to understand fully what is proposed”.’
61 In determining this issue, Nicholson CJ weighed up the expert evidence. Evidence from Mr T, who prepared the family report in the matter, stated that Alex ‘appears very knowledgeable about, and would seem to have an intellectual understanding of, the treatment process, including the stages of the treatment, some of the intended effects, as well as the side-effects of the medication and what the treatment process is’, but that it was not clear whether Alex ‘understands the full implications of the treatment’.
62 Evidence from the treating child psychiatrist noted that Alex
could appreciate ‘the nature of the proposed treatment and its consequences better than he would expect other young people his age to understand it, and that Alex has acquired this information over a fairly short space of time’.
63 However, the treating psychiatrist opined that whilst Alex fully understood the proposed treatment, its side effects, and benefits, it was ‘not appropriate’ that Alex should be wholly responsible for making the decision about commencing hormone treatment.
64 Interestingly, Nicholson CJ noted that the experts’ evidence suggested, in fact, that Alex may have been
Gillick competent or would attain this threshold shortly after the application was made to the court. Despite this, his Honour concluded that the matter should be decided by the court.
65Nicholson CJ rejected the submission made by the Human Rights and Equal Opportunity Commission (intervener in the matter) that once a child achieves a sufficient understanding and intelligence to enable them to understand fully what is proposed, the court has no further involvement.
66 Nicholson CJ concluded that it was not “appropriate” for Alex to make the decision despite stating that the ‘question of best interests does not really inform the primary decision [that must be made] which is whether [the minor] has the necessary capacity’.
67 Nicholson CJ considered that the nature of the decision about consenting to hormone treatment should be distinguished from a decision about contraceptive advice and treatment.
68 It was further stated that ‘[i]t is highly questionable whether a 13 year old could ever be regarded as having the capacity [to consent to Stage 1 and Stage 2 treatment], and this situation may well continue until the young person reaches maturity’.
69 Ultimately, Nicholson CJ did not conclude on Alex’s competency, noting that it would be in Alex’s best interests to undergo the treatment in question, and that ‘the capacity of Alex to give his own consent would be an academic question’ unless the application were refused.
70In the years after
Re Alex was decided, the issue of whether Stage 1 treatment fell within the boundaries of parental consent or should be subject to court approval was questioned by some judges.
71 In 2013, this resulted in an appeal to the Full Court of the Family Court of Australia (Full Court) in
Re Jamie.
72 This is an important decision as it adopted a different approach to Nicholson CJ in
Re Alex, and thereby set a precedent for future Family Court applications. The Full Court noted that
Re Alex should be distinguished as it focused on whether a government department could provide consent to treatment for gender identity disorder (as it was then termed under the DSM IV), under the scope of an operative care order, rather than parental consent.
73 The Full Court held that parents can lawfully consent to Stage 1 treatment, but not Stage 2. Bryant CJ explained that this approach could be justified because in
Re Alex the court ‘was asked not to view the reversible first stage [of treatment] in isolation from the second stage, which could have irreversible consequences’,
74 but instead, to consider both stages together as a single treatment plan. The Full Court considered and applied the reasoning in
Marion’s Case, holding that Stage 1 treatment is therapeutic as it is intended to treat a psychological condition, and that court approval for the commencement of Stage 1 treatment should no longer be necessary, therefore bringing it within the parental power to consent. In relation to the “further factors” from
Marion’s Case, it was reasoned that they did not apply to Stage 1 treatment in the same way that they applied to non-therapeutic sterilisation. Thus, Bryant CJ did not think that it was likely that there would be a conflict of interests between the parties involved. Her Honour stated ‘it is unlikely that the parental interests [in the context of Jamie’s treatment] would be anything other than the welfare of the child (as opposed to having a collateral interest in having the treatment carried out)’.
75 Despite this, the Full Court concluded that applications to the court should continue to be required in respect of Stage 2 treatment and that parents could not consent to this treatment, based on its irreversible and serious consequences. This reasoning has received significant criticism based on the application of
Marion’s Case, particularly because the Full Court held that Stage 1 treatment for gender dysphoria is therapeutic and thereby outside the reasoning of the High Court in
Marion’s Case. Others have observed that if Stage 1 treatment fell within the parental power to consent based on its therapeutic nature, this should also apply to Stage 2 treatment (
Smith 2013;
Bell 2015;
Stewart 2017). Interestingly, the Full Court also decided that in circumstances where a minor is assessed as
Gillick-competent by their treating health professionals, an application
must be made to the court so that the court could confirm the minor’s competency for the purpose of consenting to the treatment.
76When considering the issue of
Gillick competency in
Re Jamie, Bryant CJ made reference to the United Nations’ Convention on the Rights of the Child.
77 In particular, Article 12, which requires assurance that a child who is ‘capable of forming his or her own views’ has a right to express those views freely in all matters that affect them, and that such views be given due weight in accordance with the age and maturity of the child.
78 Submissions made to the Full Court by the Public Authority in respect of how the court should approach the
Gillick competency of the minor outlined that irrespective of whether or not the minor is considered to be
Gillick competent, the court should ‘retain and exercise its role as an oversighting body’.
79 Bryant CJ seemed to accept this proposition that it is the court that should determine the matter of
Gillick competency in such cases, despite noting:
In my view, it would be contrary to the Convention on the Rights of the Child, and to the autonomous decision-making to which a
Gillick competent child is entitled, to hold that there is a particular class of treatment, namely stage two treatment for childhood gender identity disorder, that disentitles autonomous decision-making by the child, whereas no other medical procedure does. The High Court in Marion’s case, adopting the formulation in
Gillick, held at 237 that a child is capable of giving informed consent when he or she “achieves a sufficient understanding and intelligence to enable him or her to understand fully what is proposed”.
80
Indeed, it was further stated that ‘one might think that, of all the medical treatments that might arise, treatment for something as personal and essential as the perception of one’s gender and sexuality would be the very exemplar of when the rights of the
Gillick-competent child should be given full effect’.
81 However, Bryant CJ concluded that it is the court that should determine, or at least, confirm, the minor’s competency,
82 which was similarly the conclusion of Finn J
83 and Strickland J.
84 Bryant CJ explained the reason for such a conclusion:
In Marion’s case, the majority held that court authorisation was required first because of the significant risk of making the wrong decision as to a child’s capacity to consent, and secondly because the consequences of a wrong decision are particularly grave.
It seems harsh to require parents to be subject to the expense of making application to the court with the attendant expense, stress and possible delay when the doctors and parents are in agreement but I consider myself to be bound by what the High Court said in
Marion’s case.
85
It can be seen here that the “further factors” from
Marion’s Case are brought into the discussion of
Gillick competency to justify the court’s involvement with confirming the minor’s capacity. It was confirmed that such an application would only need to address the issue of the minor’s
Gillick competency and if the minor’s capacity is confirmed by the court, there is no further role for the court in the matter.
86Following this decision, as the number of applications to the Family Court increased year by year, judges were beginning to question the Full Court’s approach in
Re Jamie, raising the question about whether there was a need to involve the court for Stage 2 treatment.
87 Four years after the Full Court decided
Re Jamie, the law again required clarification when Watts J referred a number of questions to the Full Court for determination by way of a case stated.
88 The Full Court in
Re Kelvin89 was asked to clarify the legal position surrounding parental consent for Stage 2 treatment and whether this treatment fell outside the boundaries of parental consent. The Full Court was also required to clarify whether the court must confirm the minor’s competency to consent to hormone treatment for gender dysphoria. The Full Court held that parents for non-competent children and
Gillick competent minors can lawfully consent to both Stage 1 and Stage 2 treatment without the need for court involvement, where treatment is provided in accordance with national and international treatment guidelines and standards.
90 However, it was also held that in cases of “controversy”—that is, where there is a
genuine disagreement or controversy between the decision-makers and/or clinical team about whether treatment should commence—an application must be made to the court. Indeed, it is important to note that the Full Court in
Re Kelvin, stated that a controversy occurs where there is disagreement ‘about whether the
treatment should be administered’,
91 and it is worth highlighting that the reasoning of the majority does not specifically mention a controversy as including parental disagreement with the conclusion of the treating medical practitioner about the minor’s competency.
The Full Court in
Re Kelvin agreed that it was necessary to depart from the Court’s earlier decision in
Re Jamie. However, there were different reasons underpinning the conclusions of the majority and minority judgments. The majority in
Re Kelvin noted that it is generally permissible to depart from an earlier decision if that decision is found to be “plainly wrong”.
92 The applicant, the Independent Children’s Lawyer, and some of the interveners submitted that the decision in
Re Jamie was plainly wrong, particularly the Court’s application of the reasoning in
Marion’s Case.
93 However, the majority concluded that ‘it is unnecessary and indeed inappropriate for this Court to find that
Re Jamie was “plainly wrong” in order to answer’ the relevant questions referred to the court.
94 Instead, the majority departed from that decision on the basis that ‘there is a factual difference between the two cases that has relevant legal significance, [such that] there has been a change in the factual understanding on which the earlier decision [in
Re Jamie] was based’.
95 In contrast, the minority reached the view that the decision in
Re Jamie was “plainly wrong” and as a result, the decision should be departed from. The approach in
Re Kelvin was summarised by Watts J in
Re Imogen (No. 6)96 (‘
Re Imogen’):
In Re Kelvin, the Full Court determined that:
a. Given the current state of medical knowledge, stage 2 treatment was therapeutic and was treatment for which consent no longer lies outside the bounds of parental authority or requires the imprimatur of the court (reversing the position in Re Jamie), and
b. In respect of stage 2, if the child, the parents and the medical practitioners agree a child is Gillick competent, there was no need for the Court to determine Gillick competence (reversing the position in Re Jamie), and
c. If all agree, a Gillick competent child can consent to stage 2 treatment, and
d. If a child is not
Gillick competent and the treating medical practitioners agree, the child’s parents can consent to stage 2 treatment without court approval.
97
Although it was initially thought that the Full Court had clarified the law in
Re Kelvin, and that generally there is no need to involve the court except in cases of controversy, there is subsequent case law that confuses the position. In
Re Imogen, Watts J held that because the majority in
Re Kelvin did not determine that
Re Jamie was “plainly wrong”, there are elements of
Re Jamie that remain as binding precedent. Hence, Watts J held in
Re Imogen that there are some instances where an application to the court must still occur. His Honour stated that in cases where a parent or medical practitioner disputes either the minor’s
Gillick competence, the diagnosis of gender dysphoria, or the proposed treatment, then an application to the court is
mandatory.
98 It was held that if the only dispute is about the minor’s
Gillick competency, then the court should determine this by way of a declaration and that this is not a best interests consideration.
99 If there is a dispute about diagnosis or treatment, then the court must resolve this and determine the diagnosis and treatment, and make appropriate orders based on best interests considerations.
100 Watts J also added that ‘if a parent or legal guardian does not consent to an adolescent’s treatment for gender dysphoria, a medical practitioner, who is willing to do so, should not administer treatment to an adolescent who wishes it, without court authorisation’.
101 For this purpose,
Re Imogen imposes a requirement that parental consent must be obtained
in addition to the consent of the minor, even if the minor is
Gillick competent. Thus, Watts J summarised:
This judgment confirms the existing law is that any treating medical practitioner seeing an adolescent under the age of 18 is not at liberty to initiate stage 1, 2 or 3 treatment without first ascertaining whether or not a child’s parents or legal guardians consent to the proposed treatment. Absent any dispute by the child, the parents and the medical practitioner, it is a matter of the medical professional bodies to regulate what standards should apply to medical treatment. If there is a dispute about consent or treatment, a doctor should not administer stage 1, 2 or 3 treatment without court authorisation.
102
Watts J does not reference specific reasoning in the judgment of
Re Jamie or
Re Kelvin to support his conclusions in this regard. As noted by
Jowett and Kelly (
2021, p. 45), the legal basis for such an approach is not clear, and ‘[i]n Watts J’s view, his judgment merely clarified law laid out by the Full Court in
Re Jamie and
Re Kelvin, which requires court intervention in the case of “parental dispute”’. In Part Four of this article, I analyse not only the approach of Watts J in
Re Imogen in relation to
Gillick competency, but also the earlier key decisions discussed above, in terms of how they have applied the reasoning in
Gillick. As I argue, Australian law on this topic is not based on a consistent application of the reasoning in
Gillick, nor its subsequent interpretation, and from the very first decision relevant to gender affirming treatment, has gone astray in its interpretation and application of the
Gillick test.
3.2. The English Decisions in Bell
Before turning to my analysis of the existing law, it is important to also outline the recent English jurisprudence that has considered the issue of whether a
Gillick competent minor can consent to hormone treatment for gender dysphoria.
103 This is relevant because the interpretation of the
Gillick test in this context was clarified by the English Court of Appeal.
104 In the judicial review claim of
Quincy Bell and Mrs A v The Tavistock and Portman NHS Foundation Trust and Ors (‘
Bell’),
105 the claimants attempted to challenge the lawfulness of the consent processes of the Gender Identity Development Service (GIDS) at the Tavistock and Portman NHS Trust (Trust) concerning Stage 1 treatment for minors with gender dysphoria. The GIDS’s policy recognised that a minor may consent to hormone treatment for gender dysphoria. However, the English High Court concluded that minors below 16 years of age are not ever likely to be regarded as
Gillick competent to consent to Stage 1 treatment. Although this approach was subsequently overturned by the Court of Appeal in September 2021, an examination of the approach in the High Court decision is warranted because of the conclusions reached about the concept of
Gillick competency, and some of the similarities that such conclusions share with the Australian jurisprudence.
106The claimants argued that minors would never be Gillick competent to consent to the commencement of gender affirming care. Outlining the treatment pathway, the High Court noted that minors may be referred to two other NHS Trusts (the first and second interveners in the claim) and then proceed with gender affirming care, if determined appropriate, under the care of those NHS Trusts. The English High Court held that the decision to commence gender affirming treatment, along with its unknown risks and consequences, is so significant that a minor below 16 years of age was unlikely to understand the implications of such a decision. The High Court determined that the commencement of Stage 1 treatment was effectively a clinical pathway to Stage 2 treatment, and for this reason, the minor must understand all stages of treatment at the time they commence the first stage. It was stated:
It follows that to achieve
Gillick competence the child or young person would have to understand not simply the implications of taking [puberty blockers (PBs)] but those of progressing to cross-sex hormones [CSH]. The relevant information therefore that a child would have to understand, retain and weigh up in order to have the requisite competence in relation to PBs, would be as follows: (i) the immediate consequences of the treatment in physical and psychological terms; (ii) the fact that the vast majority of patients taking PBs go on to CSH and therefore that s/he is on a pathway to much greater medical interventions; (iii) the relationship between taking CSH and subsequent surgery, with the implications of such surgery; (iv) the fact that CSH may well lead to a loss of fertility; (v) the impact of CSH on sexual function; (vi) the impact that taking this step on this treatment pathway may have on future and life-long relationships; (vii) the unknown physical consequences of taking PBs; and (viii) the fact that the evidence base for this treatment is as yet highly uncertain.
107
On appeal, the Court of Appeal disagreed with the High Court’s conclusions. The Court of Appeal overturned the decision, referring to the fact that the claim was a judicial review action, rather than a decision about a specific minor’s competence. It was also concluded that the High Court had not found that there was illegality in the policy or practice of the defendants.
108 With reference to Lord Fraser and Lord Scarman’s approach in
Gillick, the Court of Appeal stated that their Lordships’ approach in
Gillick was to provide relevant
guidance for determining the minor’s competency.
109 The Court of Appeal stated that the factors provided as guidance in
Gillick were ‘an area for evaluation, rather than a conclusory statement of fact or medical opinion’
110 and that some of the eight elements outlined by the English High Court (quoted above), failed to align with the approaches of Lord Fraser and Lord Scarman in
Gillick.
111 When interpreting the
Gillick test, the Court of Appeal held that the different aspects of the guidance found in the
Gillick judgment were not intended to serve as statements of law,
112 and that the High Court in
Bell ‘was not in a position to generalise about the capability of persons of different ages to understand what is necessary for them to be competent to consent to the administration of puberty blockers’.
113 To put it clearly and without doubt, it was stated:
The
ratio decidendi of
Gillick was that it was for
doctors and
not judges to decide on the capacity of a person under 16 to consent to medical treatment. Nothing about the nature or implications of the treatment with puberty blockers allows for a real distinction to be made between the consideration of contraception in
Gillick and of puberty blockers in this case bearing in mind that, when
Gillick was decided 35 years ago, the issues it raised in respect of contraception for the under 16s were highly controversial in a way that is now hard to imagine.
114
The Court of Appeal did conclude that the issues raised in the context of minors consenting to gender affirming hormone treatment, are complex, and that:
They raise all the deep issues identified in
Gillick, and more. Clinicians will inevitably take great care before recommending treatment to a child and be astute to ensure that the consent obtained from both child and parents is properly informed by the advantages and disadvantages of the proposed course of treatment and in the light of evolving research and understanding of the implications and long-term consequences of such treatment. Great care is needed to ensure that the necessary consents are properly obtained. As
Gillick itself made clear, clinicians will be alive to the possibility of regulatory or civil action where, in individual cases, the issue can be tested.
115
This clarifies the position under English law; that the assessment of a minor’s competency is for medical practitioners to determine rather than the courts. This reasoning should be considered carefully in Australia moving forward. It is logical that the future direction of Australian law should be influenced by the English common law on this point, given that Australia adopted the
Gillick principle from English law. Even if there are some differences in the subsequent interpretation of
Gillick under Australian law, such as McHugh J in
Marion’s Case suggesting that the parental power is at an end in all respects once the minor achieves a sufficient degree of understanding and maturity to make their own decisions, this does not provide an impetus to disregard other English jurisprudence that interprets
Gillick. It is important to note that the Court of Appeal’s interpretation of
Gillick in the
Bell decision is not inconsistent with
Gillick. Thus, McHugh J’s statement in
Marion’s Case about not following post-
Gillick caselaw from England, was made on the basis that such reasoning (specifically, that expressed by Lord Donaldson in
Re R) was
inconsistent with
Gillick.
116 Hence, authority that interprets and applies
Gillick in a manner that is consistent with the House of Lords reasoning would continue to be highly influential in Australia.
4. Analysis of the Gillick Test as Applied under Australian Law in Cases Concerning Minors and Gender Affirming Treatment
Building on the overview of the law outlined in Part 3, in this section of the article I analyse the law and demonstrate how the application of the Gillick principle was taken off track in the cases relevant to gender affirming hormone treatment. I consider how Gillick is applied across the spectrum of key decisions in this field, to highlight the problems with the approach adopted in this body of jurisprudence.
From the outset, Australian case law concerning gender affirming hormone treatment for minors has adopted a paternalistic approach to the Gillick principle. The approach adopted in many of the Australian cases suggests that the role of medical practitioners in assessing and determining the minor’s competency, should be assumed by the courts, which appears to be inconsistent with the approach in Gillick, and as confirmed in subsequent jurisprudence (such as the Court of Appeal’s conclusions in Bell).
In Re Alex, as outlined above, Nicholson CJ did not ultimately conclude on the issue of whether Alex had the capacity to consent, despite acknowledging that in line with Marion’s Case and as a threshold question it was necessary to consider Alex’s competency.
When reading Nicholson CJ’s conclusions, his reasoning suggests that Alex was at least potentially
capable of reaching the threshold of understanding required for
Gillick competency—either at the time of the application or shortly after. As outlined above,
Gillick suggests that the correct approach is to determine whether the minor is
capable of reaching the level of understanding required. In the context of Alex’s understanding and based on the evidence discussed, this seemed possible. Nevertheless, Nicholson CJ did not conclude on Alex’s competency. What also appears inconsistent in Nicholson CJ’s reasoning is that he stated that the ‘question of best interests does not really inform the primary decision [that must be made] which is whether [the minor] has the necessary capacity’, but concluded that it was not
appropriate for Alex to make the decision.
117 This might be explained by the reasoning that Nicholson CJ believed gender affirming hormone treatment should be distinguished from decisions about contraceptive advice and treatment. However, the reference to the appropriateness of making the decision suggests that best interests considerations ultimately took precedence and had a significant bearing on the findings in relation to Alex’s competency.
Decisions about Alex’s treatment came before the court again in 2009 in the form of an application seeking the court’s approval for surgery in the form of a bilateral mastectomy.
118 Nicholson CJ’s approach in the earlier application relating to Alex appear to influence this subsequent decision. Much of the evidence relevant to this later application suggested that Alex was indeed capable of understanding the nature and consequences of the decision, and it was noted that ‘Alex is an intelligent, thoughtful, reflective and creative young person with well developed adaptive skills’.
119 However, Bryant CJ, who determined this application in 2009, stated:
… I am not satisfied that Alex is not
Gillick competent and therefore unable to himself consent to the surgery. However, as the parties, the [Independent Children’s Lawyer] and the intervenor have not led evidence nor made submissions on this matter, I am reluctant to make a positive finding to that effect. The most appropriate course of action, it seems to me, is for me to adopt the same approach as that of Nicholson CJ in the earlier proceedings, which is to take the view that the issue of
Gillick competence is academic unless I intend to make orders not permitting the procedure. Alex’s maturity and likely
Gillick competence however provide further support for the orders I made.
120
Bryant CJ made the decision based on best interests considerations. Although noting that her Honour was limited by the evidence before her, the conclusion about Alex’s competency seems at odds with the view that the minor’s
Gillick competency should be determined as a threshold matter.
121 If the determination of a minor’s competency is indeed a threshold matter, it is not logically an “academic” question that the court can choose to gloss over. It might also be argued that some of Bryant CJ’s earlier reasoning from this application, appears to influence the leading judgment that her Honour later delivered in
Re Jamie.
When the Full Court addressed the issue of the minor’s
Gillick competency in
Re Jamie, like the earlier decisions, it was noted that the determination of the minor’s competency is a threshold matter.
122 Indeed, in
Re Jamie, Bryant CJ found that in circumstances where the minor is found to be
Gillick competent, there remains no role for the Court. Her Honour reasoned that:
it would be contrary to the Convention on the Rights of the Child, and to the autonomous decision-making to which a
Gillick competent child is entitled, to hold that there is a particular class of treatment, namely stage two treatment for childhood gender identity disorder, that disentitles autonomous decision-making by the child, whereas no other medical procedure does. The High Court in
Marion’s case, adopting the formulation in
Gillick, held at 237 that a child is capable of giving informed consent when he or she “achieves a sufficient understanding and intelligence to enable him or her to understand fully what is proposed”.
123
In contrast to Nicholson CJ’s view in
Re Alex, Bryant CJ reasoned that there was no justification for reading down the significance of a conclusion that the minor is
Gillick competent, simply ‘because the treatment is for childhood gender identity disorder’.
124 It was noted that the significance of the decision relating to ‘one’s gender and sexuality would be the very exemplar of when the rights of the
Gillick-competent child should be given full effect’.
125 Despite appropriately recognising the foundational aspects of the
Gillick principle, the Full Court held that because of the nature of Stage 2 treatment, the court should retain its oversight of such treatment, including confirming the minor’s competency to consent.
The issue with the Full Court’s approach is that it merges issues relevant to parental consent with concepts relevant to decision-making by
Gillick competent minors. Bryant CJ acknowledges in
Re Jamie that ‘if the child is
Gillick competent court authorization of the special medical procedure is not necessary’,
126 thus suggesting that concepts relevant to special medical procedures are different to those relevant to the minor’s
Gillick competency. As also explained above, in
Re Jamie the Full Court relied on the “further factors” from
Marion’s Case to justify the court’s oversight in terms of assessing the minor’s competency, pointing to the significant risk of making a wrong decision about the minor’s capacity to consent, and referring to the gravity of a wrong decision.
127 However, this overlooks the fact that the focus of the High Court in
Marion’s Case when outlining the further factors was on the issue of
parental consent. Thus, the court was considering substitute decision making—that is, the issue of whether it was appropriate that very significant decisions might be made by
others (in that case, parents) for an individual who is not competent (on the facts, a child), without the court’s involvement. This focus in
Marion’s Case on the risk of making a wrong decision was not situated within a discussion of whether a competent minor could make such a decision for themselves. Moreover, the High Court in
Marion’s Case was cognisant of the dangers that might exist when
others make decisions for persons with intellectual disability, and in particular, the risk of a wrong decision, and incorrect assumptions, being made, about an individual’s capacity due to the impact of such an intellectual disability. This is noted by Felicity
Bell (
2015, p. 446):
Having described the Gillick test, the majority [in Marion’s Case] noted that “the fact that a child suffers an intellectual disability makes consideration of the capacity to consent a different matter”. The majority explained that this was due to the widely differing capabilities of children with disabilities, who cannot be treated as homogenous. Importantly, their Honours concluded “there is no reason to assume that all disabled children are incapable of giving consent to treatment”.
Bell (
2015, p. 446) relevantly notes that in this context, the High Court was cautious about not having decisions overseen by the court because it cannot be assumed that ‘medical professionals would always make “correct” decisions’, in a situation where the individual is not capable of making their own decision. Thus, the majority in
Marion’s Case ‘clearly distinguish the assessment of competency in the case of children with intellectual disabilities from the assessment of those without’ and it is the presence of intellectual disability that results in the conclusion that there is a risk of making a wrong decision when others are making decisions about the child’s future capacity to consent (
Bell 2015, p. 447).
Bell (
2015, p. 447) concludes that ‘
Marion’s Case does not mandate a finding that such a risk is automatically present in cases involving children with gender dysphoria nor the asserted consequence that it is for a court alone to make the assessment of competence’.
When
Re Kelvin was decided, it appeared to depart from earlier authority or
Re Jamie and thus signal a change in the law. Interestingly, the majority in
Re Kelvin addressed the influence of the “further factors” on the conclusions reached in
Re Jamie as a basis for justifying court oversight for the specific issue of confirming the assessment of minors’ competency. Submissions to the Full Court in
Re Kelvin suggested that Bryant CJ had erred on this point, ‘because nothing was said in
Marion’s case about who should determine
Gillick competence, and certainly it was not suggested that the court should be tasked with that responsibility’.
128 The majority noted:
What her Honour is saying is that because court authorisation is required where there is the significant risk of making the wrong decision and the consequences of a wrong decision are particularly grave, it was also appropriate that the Court determine Gillick competence. In other words, the nature of the treatment requires that to be the case (also see Finn J at [185]–[186]).
Now, of course, if as appears to be the case, the nature of the treatment no longer justifies court authorisation, and the concerns do not apply, then there is also no longer a basis for the Court to determine
Gillick competence.
129
In this regard, it appears that the majority is saying that it is no longer
necessary for the court to confirm the
Gillick competency of minors, as the concerns about Stage 2 treatment no longer justify the court’s involvement (except in cases of controversy). These conclusions were based on the change in understanding of gender dysphoria as a condition, as well as its treatment.
130 Of course, the majority acknowledged that court involvement may be required in cases of genuine dispute, and the meaning of controversy in this respect was noted to relate to decisions about the commencement of treatment. However, there is nothing in the Full Court’s reasoning in
Re Kelvin that suggested parental consent was needed in addition to the consent of a
Gillick competent minor, nor that the court
must confirm the minor’s competency if the parent disagrees with the clinician’s assessment. Indeed, the minority also arrive at this same conclusion. Ainslie-Wallace and Ryan JJ conveniently summarise the key aspects of
Marion’s Case and relevantly note that ‘[a]t common law, a parent is no longer capable of consenting on the child’s behalf when the child achieves a sufficient understanding and intelligence to enable him or her to fully understand what is proposed’.
131 They also conclude that
Marion’s Case does
not ‘[s]upport court intervention in relation to therapeutic procedures to which a legally competent person can consent’.
132Following the Full Court’s decision in
Re Kelvin, medical practitioners, quite reasonably, concluded that a minor who is regarded as
Gillick competent can lawfully consent to gender affirming treatment, and that there is no need for parental consent in addition to this. Thus, the initial version of the
Australian Standards of Care and Treatment Guidelines for Trans and Gender Diverse Children and Adolescents, stated that ‘[a]lthough obtaining consent from parents/guardians for commencement of hormone treatment is ideal, parental consent is not required when the adolescent is considered to be competent to provide informed consent’.
133 This is a logical conclusion because as outlined earlier in this article, such a view accords with reasoning from the House of Lords decision in
Gillick, which stated that whilst it is recommended that parental consent be obtained where possible, a competent minor may consent without parental involvement, and that such a consent when appropriately obtained provides the practitioner with a defence under the law of assault and trespass to the person. Furthermore, when considering this position from the perspective of the decision in
Axon, not only would parental consent in addition to the competent minor’s consent not be required, but the minor would be entitled to expect confidentiality in respect of their decision so that they could make the decision without parental involvement. However, as outlined above, in
Re Imogen Watts J held that the approach proposed under the Australian standards was not an accurate reflection of the law and that parental consent was required
in addition to the consent of the minor. Similarly, his Honour also concluded that in cases where a parent disagrees with the medical practitioner’s assessment of the minor’s competency, an application to the court is required. As noted by
Jowett and Kelly (
2021, p. 45):
It was the conclusion of Watts J that where there is a dispute about any of diagnosis, treatment or competency, the matter should come before the Court. The legal basis for this conclusion is not clearly articulated in Re Imogen. In Watts J’s view, his judgment merely clarified law laid out by the Full Court in Re Jamie and Re Kelvin, which requires court intervention in the case of “parental dispute”. We acknowledge that Watts J was bound by the Full Court decisions in Re Jamie and Re Kelvin to the extent that the existence of a parental dispute may give rise to a role for the court. However, his Honour’s interpretation of those judgments to allow for any type of dispute to usurp the wishes of a competent young person represents in our view a novel incursion on Gillick competency.
The above analysis demonstrates a range of significant issues in terms of how Gillick has been applied in Australian cases relevant to decisions about gender affirming treatment. This has culminated in a position, outlined by Watts J in Re Imogen, that is concerning for several key reasons, as I outline below. Although others have critiqued the decision in Re Imogen, my analysis adds to the existing literature on this topic as it moves beyond an analysis of individual judicial decisions, and considers the Australian jurisprudence more broadly on this topic for the purpose of situating it within a contemporary judicial understanding of Gillick.
First, the current legal position in Australia exposes some minors who may not have the support of all family members, to the unnecessary delay, expense, and stress
134 of having to seek the approval of the court in circumstances where they have been assessed as
Gillick competent by their treating practitioners. If the minor is deemed
Gillick competent by their treating clinicians, an application to the court should not be necessary. If hormone treatment is a real prospect for the minor, the proposed treatment would not normally be suggested unless the treating team have determined that it is clinically appropriate and in the minor’s best interests, as is required under the national standards of care (
Telfer et al. 2021, pp. 23–24). The law is clear, in that the
Gillick competent minor has a lawful right to consent in such circumstances without the need for parental consent. Thus, the requirement to involve the court in such circumstances is unnecessary and potentially exposes some young trans and gender diverse persons, to harm.
Second, the current legal position in Australia diminishes the significance of the
Gillick principle in terms of how it applies to decisions about consenting
to treatment. Indeed, Bryant CJ in
Re Jamie noted that there was no need to read down the rule in
Gillick because the decision was about hormone treatment for gender dysphoria rather than contraceptive advice and treatment.
135 This should, in theory, give full recognition to the principle of
Gillick competency, thereby allowing the minor to consent
to treatment (especially treatment that is regarded as in their best interests), bringing an end to the parental power in this respect. As outlined above, Family Court judges have frequently recognised that the issue of the minor’s
Gillick competency is a threshold issue to be determined in such cases, and if the minor’s competency is confirmed, the parental power for that purpose is at an end and the court has no further involvement. Yet, this is not reflected in the current position that requires parental consent
in addition to the consent of a
Gillick competent minor. Watts J’s reasoning in this regard is inconsistent with the well-established approach that the
Gillick competent minor can lawfully consent to treatment in their best interests, and that the parental power is at an end. Indeed, as noted by Lord Scarman in
Gillick, parental rights are extinguished in respect of the minor where they are no longer required to protect the child from harm, and although Lord Fraser adopted a different approach in this regard, it might be argued that subsequent English jurisprudence such as
Axon has favoured Lord Scarman’s approach on this point. Given that the proposed treatment under the Australian standards is only considered when appropriate and in the minor’s best interests, there is no basis to require parental consent. Such a situation does not fall within any of the post-
Gillick cases that contemplate that a minor’s decision to consent to treatment can be limited, as the decisions in the gender affirming treatment cases are not decisions about refusing treatment that is contrary to the minor’s best interests. Consequently, the Australian Family Court has taken the
Gillick principle off course and has interpreted
Gillick in a way that intrudes upon the minor’s right to consent to medical treatment. Such an interpretation is not supported by the jurisprudence relevant to
Gillick.
Third, the current approach in Australia not only fails to accord with the foundational reasoning in
Gillick (that is, that a competent minor can lawfully consent
to treatment), but it also destroys a fundamental and underlying basis of the
Gillick decision itself. As established, one of the key policy reasons in
Gillick for allowing the minor to consent is to preserve the minor’s confidence. This position—which recognises the right of the competent minor to make decisions about their medical treatment in a sphere of confidence—has been confirmed in subsequent English decisions.
136 In practical terms, Watts J’s approach in
Re Imogen removes this protection from the
Gillick competent minor and
mandates that parents must also consent. Although the relevant standards of care in Australia recognise the involvement of family members in terms of supporting the minor’s journey and transition (
Telfer et al. 2021, pp. 9–11, 17–21), parental support may not always be available. Indeed, in cases like
Re Alex where the minor is under the care of a local authority, such a requirement may add a significant hurdle and possible distress to the minor, and others involved. In addition, the issue of parental support and involvement is not synonymous to the giving of a legally valid consent. The involvement of family members in terms of supporting the individual, is legally distinct from the concept of consenting to treatment. Although the two may often overlap, this will not always be the case. Consequently, the requirement to obtain the consent of the
Gillick competent minor’s parents
requires that the parents are provided with private and confidential information. Under the current law,
Gillick competent minors have no choice but to agree to such a disclosure, despite them being assessed as competent by their treating practitioners. Such a position erodes the concepts of privacy and confidentiality, and thus contradicts the policy reasoning that underpinned
Gillick. This is an unsatisfactory position for the law to adopt and does not reflect the position in relation to other types of medical treatment, in circumstances where Bryant CJ had explicitly acknowledged that there was no need to read down the significance of the
Gillick principle. Moreover, in jurisdictions that have human rights legislation, such as the Australian Capital Territory,
137 Queensland,
138 and Victoria,
139 which directly protects the human right to privacy and/or a private and family life,
140 the
requirement to involve the parents may, in some cases where care is provided in the public sector, result in a potential violation of a
Gillick competent minor’s human rights.
Fourth, the approach suggested by Watts J is inconsistent with basic principles around the law of consent, that require consent as a basis for negating liability for trespass to the person and/or assault. If consent is provided by someone with lawful authority to give such consent, this is normally sufficient for the purpose of negating such liability. As outlined above, although the reasoning from the refusal cases is not directly binding in the context of decisions about consenting
to treatment, the reasoning in these cases concerning basic consent principles supports the view that parental consent is not required in addition to the consent of the competent minor. In the refusal cases, English courts have confirmed that in situations where the minor is refusing life-saving treatment contrary to their own best interests, a parent can lawfully consent to the treatment and this will protect the health professional from liability in assault and/or trespass to the person.
141 Thus, to re-emphasise Lord Donaldson’s comments in
Re W, he stated that consent:
protects the doctor from claims by the litigious whether he acquires it from his patient, who may be a minor over the age of 16 or a “
Gillick competent” child under that age, or from another person having parental responsibilities which include a right to consent to treatment of the minor. Anyone who gives him a flak jacket (ie consent) may take it back,
but the doctor only needs one and so long as he continues to have one he has the legal right to proceed.
142
This basic principle should similarly apply in the context of Gillick competent minors who wish to consent to gender affirming treatment. Thus, based on such reasoning, if the health professional has obtained a consent from a person who can lawfully provide such consent, such as a Gillick competent minor, then this should protect the health professional from a claim in assault and/or trespass to the person. Although, of course, the courts have recognised that there may be other professional consequences for failing to follow professional standards, it must be remembered that the main purpose of a lawful and valid consent is to negate criminal and civil liability for assault and trespass, and the post-Gillick caselaw has emphasised this.
Fifth, the position outlined by Watts J in terms of the need for the court to confirm the assessment of the minor’s competency, is based on reasoning from Re Jamie that is arguably no longer applicable following the Full Court’s decision in Re Kelvin. As outlined above, Bryant CJ relies on reasoning from Marion’s Case to justify court oversight of clinical assessments of the minor’s competency. As explained, this incorrectly merges the High Court’s reasoning in Marion’s Case concerning the risks inherent in parental decision-making for “special” cases, with the principles applicable to decisions made by Gillick competent minors. Given that the Full Court in Re Kelvin appears to accept that there is no longer the same degree of concern about gender affirming treatment since Re Jamie was decided, and general oversight of Stage 2 treatment is no longer required, this raises the question of why court involvement is still required in respect of minors who would ordinarily have a lawful basis to provide consent without seeking the court’s sanction. Such an approach is also contradicted by the more recent decision of the English Court of Appeal in Bell, which clearly notes that the assessment of the minor’s competency is for clinicians to make. Thus, it was stated that ‘[t]he ratio decidendi of Gillick was that it was for doctors and not judges to decide on the capacity of a person under 16 to consent to medical treatment’. Like Bryant CJ in Re Jamie, and the Full Court in Re Kelvin, the English Court of Appeal concluded that:
Nothing about the nature or implications of the treatment with puberty blockers allows for a real distinction to be made between the consideration of contraception in
Gillick and of puberty blockers in this case bearing in mind that, when
Gillick was decided 35 years ago, the issues it raised in respect of contraception for the under 16s were highly controversial in a way that is now hard to imagine.
143